tiprankstipranks
Trending News
More News >
Inhibikase Therapeutics (IKT)
NASDAQ:IKT

Inhibikase Therapeutics (IKT) Market Cap & Net Worth

Compare
176 Followers

Inhibikase Therapeutics Market Cap

Inhibikase Therapeutics has a market cap or net worth of $206.15M as of Jan 16, 2026. Its market cap has increase by 740.90% in one year.
Market Cap
$206.15M
Enterprise Value
$87.89M
1-Year Change
740.90%
Category
Micro (Under 300M)
Stock Price
$1.65

Market Cap Chart

Market Cap History
Date
Market Cap
% Change
Jan 15, 2026
117.15M-2.94%
Jan 14, 2026
120.71M+1.19%
Jan 13, 2026
119.28M-1.75%
Jan 12, 2026
121.42M-0.29%
Jan 09, 2026
121.77M+2.69%
Jan 08, 2026
118.57M-11.64%
Jan 07, 2026
134.20M-5.50%
Jan 06, 2026
142.01M-0.50%
Jan 05, 2026
142.72M+2.55%
Jan 02, 2026
139.17M-4.39%